The overall objective of the project is to design nanosized intestine targeted iron supplement delivery vehicles, based on milk derived exosomes to efficiently address anaemia, prevalent among 614 million women and 200 million children worldwide, a target of the 2nd United Nations Sustainable Development Goal (SDG) “zero hunger” under the 2030 agenda. Specifically, enterocytes, which are cells responsible for iron absorption and conversion to usable forms in the body, will be targeted, and the exosomes will be functionalised with cell penetrating peptides to circumvent endocytosis, facilitating direct delivery of the iron supplement to the cytosol. This uptake by enterocytes will be tracked using Raman microspectroscopy, a label-free live cell technique, observing the molecular signatures of exosomes and the changes in the signature of iron supplements, after delivery and conversion to usable forms in human cells and in vitro intestine models.